SACM - United Kingdom
Permanent URI for this collectionhttps://drepo.sdl.edu.sa/handle/20.500.14154/9667
Browse
2 results
Search Results
Item Restricted An exploration of the perceptions and experiences of adult heart failure patients utilizing telehealth monitoring in their homes: A Qualitative Systematic Review(Saudi Digital library, 2023-12-13) Alhazmi, Raneem Mohammed Ahmed; Whittingham, Katharine; Brindley, Allison; Gee, GarethAbstract Background Heart failure (HF) is a significant health issue since affected individuals endure a substantial load of symptoms and restrictions in their physical functioning, with implications on their mental and behavioural welfare. The implementation of a telemonitoring system promises to enhance the treatment of the disease by facilitating prompt medication adjustments, early identification of signs and symptoms indicating illness progression, and fostering the adoption of self-care practices. This qualitative systematic review examines the overall experiences of adult heart failure patients who used telemonitoring equipment inside their homes as a component of follow-up treatment and self-management. Objective To identify and explore the experiences and perceptions of adult HF using TM in their homes. Methods A qualitative systematic review was performed using the JBI framework, studies released between 2010 and 2022 and the search was implemented from three central databases that have been carefully searched (CINHAL full text, MEDLINE and PUBMED). Results Seven qualitative investigations, for a total of more than one hundred patients diagnosed with heart failure using telemonitoring tools. A total of forty-nine results were identified and eight categories derive. Four synthesised results were obtained: awareness and knowledge about their condition promote reassurance and self-empowerment, continuity in care facilitates adherence to habits and self-management, patients value in-person interactions with healthcare practitioners and perceive telemonitoring systems as lacking personalized touch, patients find value in the time efficiency and user-friendliness of telemonitoring systems, but technical and economic barriers often outweigh these benefits. Conclusion TM can enhance patients' disease awareness, knowledge, and self-care competence. Patients generally reported feeling reassured and empowered through daily self-monitoring, which helped establish their healthy routines. However, the qualitative evidence indicates that patients still highly value human connection and in-person support from healthcare professionals, seeing TM as an adjunct instead of serving as a substitute for in-person interactions46 0Item Restricted Does Using Empagliflozin Reduce Hospitalization for Heart Failure and Angina in People With Diabetes? A Systematic Review(2023-05-02) Alrefaee, Manal Ibrahim; Khan, EhsanBackground Current statistics show that there are over 422 million people with diabetes around the world, and these numbers are in continuous increase (Lin et al 2020). The presence of type 2 diabetes mellitus increases the incidence of cardiovascular diseases (Leon & Thomas 2015). There is an increase trend towards using SGLT2 (Sodium Glucose Cotransporter 2) inhibitors, including empagliflozin, in the treatment of people with diabetes as the have shown beneficial effects in improving glucose control and cardiovascular events. Objectives To examine whether empagliflozin decreases hospitalizations for heart failure or unstable angina for people with type 2 diabetes mellitus (T2DM). Selection method The included studies compared using empagliflozin, 25 mg/10 mg, with placebo, no treatment. Only randomized controlled trials selected. Participants were people ≥18 years old with type 2 diabetes mellitus. Method The preferred method for conducting this systematic review was the Cochrane Handbook for Systematic Reviews (2022). The search for study was carried out through EMBASE database, PubMed, and Cochrane from 2014 to 2022. The search strategy was the PICO, (P) stands for Population, (I) Intervention, (C) Comparison, and (O) Outcome. The selected studies were assessed for quality using CASP (Critical Appraisal Skills Programme) tool. The risk of bias was also assessed using the Cochrane Risk of Bias tool (RoB2). The study search, the quality assessment and risk of bias examination all conducted by one author. Main results Four studies were retrieved for this systematic review. The studies compared using empagliflozin, 25 mg or 10 mg, with placebo, no treatment. Hospitalizations for heart failure were significantly lower in intervention groups, there is no significant difference in all-cause hospitalization, and the as no significant difference in hospitalization for unstable angina between the two groups. Conclusion Provided the notable control of diabetes status, using empagliflozin had an association with decreased hospitalization for heart failure and other cardiovascular diseases. A strong recommendation for using empagliflozin depending on the available data. The effects of empagliflozin on hospitalization for heart failure or unstable angina require more examination in the future.37 0